AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease.
Employees: 1-10
Total raised: $61M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 26.10.2023 | MPM Capita... | mpmcapital... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.10.2023 | Series A | $61M | - | vator.tv/n... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 16.10.2023 | AstronauTx, developing treatments for Alzheimer's, raises $5... | The startup works in partnership with UCL and is backed by Novartis and UK gov't funds In the Unite... | vator.tv/n... |
| 09.10.2023 | AstronauTx Raises £48M in Series A Financing | AstronauTx Ltd, a London, UK-based biotech company, raised£48m ($61m) in Series A financing. The ro... | finsmes.co... |
| 09.10.2023 | AstronauTx closes a £48 million ($61 million) Series A finan... | London UK, XXXX– AstronauTx Ltd. (“AstronauTx”), a biotech company developing novel treatments for A... | svhealthin... |
| 09.10.2023 | Novartis-backed AstronauTx heads off for Alzheimer's mission... | While the final frontier of Alzheimer’s disease work is patrolled by U.S. Big Pharmas like Eli Lilly... | fiercebiot... |